BridgeBio Pharma Inc header image

BridgeBio Pharma Inc

BBIO

Equity

ISIN null / Valor 48204826

NASDAQ (2026-07-30)
USD 82.14-1.68%

BridgeBio Pharma Inc
UMushroom community rating:

star star star star star
0.00 0 votes No rating yet
NegativeNeutralPositive

About company

BridgeBio Pharma Inc. is a publicly traded biopharmaceutical company (Nasdaq: BBIO) based in Palo Alto, California, that develops targeted therapies for genetically defined diseases and select cancers. It builds a diversified pipeline of discovery- and development-stage programs—often organized into focused operating subsidiaries—using genetic and biomarker data to guide patient selection and clinical strategy, and advancing candidates through clinical trials toward regulatory approval and commercialization through a mix of in-house development, partnerships and licensing. The company’s business model emphasizes translating genetic insights into precision medicines for rare and oncology indications while managing program-specific risk and capital allocation across its portfolio.

Summarized from source with an LLMView SourceSector: Healthcare

Latest Results ():

Summarized from source with an LLMView Source

Key figures

80.1%1Y
139%3Y
53.7%5Y

Performance

46.0%1Y
61.3%3Y
94.0%5Y

Volatility

Market cap

16088 M

Market cap (USD)

Daily traded volume (Shares)

2,515,670

Daily traded volume (Shares)

1 day high/low

27.93 / 27.25

1 day high/low (USD)

52 weeks high/low

0.00 / 0.00

52 weeks high/low (USD)

Dividend ex-date

01 January, 2022

Dividend ex-date

Dividend

0.00

Dividend (USD)

Dividend yield (p.a.)

0.00%

Dividend yield (p.a.)

0.002022
0.002023
0.002024

Est dividend (USD)

0.00%2022
0.00%2023
0.00%2024

Est dividend yield

P/E ratio

10.00

P/E ratio

00.002022
00.002023
00.002024

Est P/E ratio

EPS

0.00

EPS (USD)

0.002022
0.002023
0.002024

Est EPS (USD)

Ratings & reviews

star star star star star

0.00

0 votes
Performance:
starstarstarstarstar
0.00
Innovation:
starstarstarstarstar
0.00
Society:
starstarstarstarstar
0.00
Nature:
starstarstarstarstar
0.00

EQUITIES OF THE SAME SECTOR

Sanofi SA
Sanofi SA Sanofi SA Valor: 699381
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-8.95%EUR 72.77
Sartorius Stedim Biotech
Sartorius Stedim Biotech Sartorius Stedim Biotech Valor: 32518471
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.64%EUR 170.10
Ramsay Generale de Sante SA
Ramsay Generale de Sante SA Ramsay Generale de Sante SA Valor: 1247709
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.45%EUR 10.95
CG Oncology Inc
CG Oncology Inc CG Oncology Inc Valor: 131996952
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
5.66%USD 73.03
Glaukos Corp
Glaukos Corp Glaukos Corp Valor: 28262610
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
4.24%USD 168.52
Rainbow Childrens Medicare Limited
Rainbow Childrens Medicare Limited Rainbow Childrens Medicare Limited Valor: 118549448
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
1.34%INR 1,516.00
Boiron SA
Boiron SA Boiron SA Valor: 487646
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.36%EUR 27.30
IPCA Laboratories Limited
IPCA Laboratories Limited IPCA Laboratories Limited Valor: 115718957
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-0.72%INR 1,761.50
Teleflex Inc
Teleflex Inc Teleflex Inc Valor: 976212
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
-1.75%USD 132.30
Fresenius Medical Care AG
Fresenius Medical Care AG Fresenius Medical Care AG Valor: 523134
starstarstarstarstar

Annual Return

-50%0%+50%

Risk level

110
3.38%USD 25.70